Endothelial cell activation in thrombotic thrombocytopenic purpura (TTP): a prospective analysis

被引:7
作者
de Wit, TR
Fijnheer, R
Brinkman, HJ
Kersting, S
Hene, RJ
van Mourik, JA
机构
[1] CLB, Sanguin Res, Dept Plasma Prot, NL-1066 CX Amsterdam, Netherlands
[2] Univ Med Ctr Utrecht, Dept Haematol, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Dept Nephrol, Utrecht, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
关键词
endothelial cells; thrombotic thrombocytopenic purpura; vascular perturbation; von Willebrand factor (VWF); VWF-propeptide;
D O I
10.1046/j.1365-2141.2003.04645.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
It is generally assumed that endothelial cell injury is the primary event in the pathogenesis of thrombotic thrombocytopenic purpura (TTP). In this study, we have determined the extent of vascular perturbation during acute episodes of the disease. We performed a prospective, serial study of nine patients with relapsing TTP during hospitalization and treatment, and assessed the degree of endothelial cell involvement at admission, exacerbation and remission by measurement of von Willebrand factor (VWF) and VWF-propeptide levels. Measurement of both VWF and its propeptide enabled discrimination between acute and chronic perturbation of the endothelium. Elevated levels of both VWF and propeptide were found at admission. These levels decreased immediately upon plasma exchange therapy. However, plasma VWF and propeptide concentrations did not change, even at the time of acute exacerbation. These observations suggest that endothelial cell activation is not the primary event leading to TTP. Vascular perturbation seems to be a consequence, rather than a cause, of the disease.
引用
收藏
页码:522 / 527
页数:6
相关论文
共 15 条
[11]   Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q: Inhibition by doxycycline and by monoclonal antibody VP-1 [J].
Tsai, HM ;
Sussman, II ;
Ginsburg, D ;
Lankhof, H ;
Sixma, JJ ;
Nagel, RL .
BLOOD, 1997, 89 (06) :1954-1962
[12]   von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura [J].
van der Plas, RM ;
Schiphorst, ME ;
Huizinga, EG ;
Hené, RJ ;
Verdonck, LF ;
Sixma, JJ ;
Fijnheer, R .
BLOOD, 1999, 93 (11) :3798-3802
[13]   von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation [J].
van Mourik, JA ;
Boertjes, R ;
Huisveld, IA ;
Fijnvandraat, K ;
Pajkrt, D ;
van Genderen, PJJ ;
Fijnheer, R .
BLOOD, 1999, 94 (01) :179-185
[14]  
van Mourik JA, 2001, THROMB HAEMOSTASIS, V86, P164
[15]  
Vischer UM, 1997, THROMB HAEMOSTASIS, V77, P387